氨基糖化物6'-N-乙转移酶Ib型对阿米卡辛耐药性的动力学和定量贡献
Ophélie d'Udekem d'Acoz1, Fong Hue2,3, Tianyi Ye1
1Department of Biology, McGill University, Montréal, Québec, Canada.
mSphere
|February 14, 2024
概括
高度的氨基糖化物6'-N-乙转移酶Ib型 (AAC(6') -Ib) 会增加大肠杆菌的阿米卡辛耐药性,直到蛋白质聚合降低有效性. 了解酶动力学是打击抗生素耐药性的关键.
科学领域:
- 微生物学 微生物学
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 抗生素耐药性,特别是对氨基甘油的耐药性,是一个主要的公共卫生问题.
- 氨基糖化物6 -N-乙转移酶类型Ib [AAC(6 ) -Ib] 是一种普遍存在的酶,使其对像阿米卡辛这样的关键药物产生耐药性.
- 细胞内行为和AAC(6 ) -Ib对抗性水平的贡献仍然不太清楚.
研究的目的:
- 量化Escherichia coli*中每个细胞的AAC(6 ) -Ib水平.
- 为了将细胞内AAC(6 ) -Ib度与阿米卡辛耐药性相关联.
- 为了研究酶聚合对阿米卡辛耐药性的影响.
主要方法:
- 使用基于光的系统量化AAC6 ) -Ib复制号.
- 使用CRISPR干扰来调节AAC6 ) -Ib表达水平.
- 进行了体内成像以观察蛋白质扩散和聚合.
主要成果:
- 阿米卡辛耐药性与AAC(6 ) -Ib度线性增加到一个高原.
- AAC6 ) -Ib在细胞质中自由扩散,但在高度下形成包容体.
- 用合剂抑制聚合部分恢复了耐药性,这表明聚合降低了酶的有效性.
结论:
- 细胞内AAC(6 ) -Ib度直接影响阿米卡辛耐药性,聚合限制了有效性.
- 细胞环境和蛋白质动态在氨基糖化物耐药性方面发挥着关键作用.
- 这项研究为开发克服抗生素耐药性的新策略提供了基础的见解.
关键词:
AAC(6′) -Ibb 的情况.克里斯普里是什么?克里斯普里是什么?埃舍里希亚大肠杆菌 (Escherichia coli) 是一个大肠杆菌.这就是阿米卡辛.抗生素耐药性 抗生素耐药性光是一种光.塑料质粒 塑料质粒是什么?更多相关视频
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
6.5K
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
603
相关概念视频
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
01:15Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
01:20Estimation of k and VD of Aminoglycosides
Aminoglycosides are a class of antibiotics used to treat various bacterial infections. Clinicians must determine the elimination rate constant (k) and volume of distribution (VD) to optimize therapeutic efficacy and minimize toxicity. The k value represents the rate at which the drug is removed from the body, and the VD reflects the degree to which the drug distributes into body tissues. Accurately estimating these parameters allows healthcare professionals to tailor drug dosing to individual...
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Inhibitors of Bacterial Protein Synthesis
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...